These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 35029940)

  • 1. Orthostatic Hypotension: A Practical Approach.
    Kim MJ; Farrell J
    Am Fam Physician; 2022 Jan; 105(1):39-49. PubMed ID: 35029940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent unexplained chest pain and dyspnea in a patient with coronary artery disease: a case report.
    Mobarek SK
    BMC Cardiovasc Disord; 2020 Feb; 20(1):54. PubMed ID: 32019498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysautonomia: A Forgotten Condition - Part 1.
    Rocha EA; Mehta N; Távora-Mehta MZP; Roncari CF; Cidrão AAL; Elias Neto J
    Arq Bras Cardiol; 2021 Apr; 116(4):814-835. PubMed ID: 33886735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation and management of orthostatic hypotension.
    Lanier JB; Mote MB; Clay EC
    Am Fam Physician; 2011 Sep; 84(5):527-36. PubMed ID: 21888303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing and treating neurogenic orthostatic hypotension in primary care.
    Kuritzky L; Espay AJ; Gelblum J; Payne R; Dietrich E
    Postgrad Med; 2015; 127(7):702-15. PubMed ID: 26012731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthostatic Hypotension.
    Am Fam Physician; 2022 Jan; 105(1):Online. PubMed ID: 35029960
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa.
    Isaacson SH; Skettini J
    Vasc Health Risk Manag; 2014; 10():169-76. PubMed ID: 24729712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials.
    Chen JJ; Han Y; Tang J; Portillo I; Hauser RA; Dashtipour K
    Ann Pharmacother; 2018 Dec; 52(12):1182-1194. PubMed ID: 29972032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Orthostatic Hypotension.
    Palma JA; Kaufmann H
    Continuum (Minneap Minn); 2020 Feb; 26(1):154-177. PubMed ID: 31996627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group.
    Low PA; Gilden JL; Freeman R; Sheng KN; McElligott MA
    JAMA; 1997 Apr; 277(13):1046-51. PubMed ID: 9091692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular Safety Considerations in the Treatment of Neurogenic Orthostatic Hypotension.
    Olshansky B; Muldowney J
    Am J Cardiol; 2020 May; 125(10):1582-1593. PubMed ID: 32204870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management Strategies for Comorbid Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension.
    Isaacson SH; Dashtipour K; Mehdirad AA; Peltier AC
    Curr Neurol Neurosci Rep; 2021 Mar; 21(4):18. PubMed ID: 33687577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New developments in the management of neurogenic orthostatic hypotension.
    Biaggioni I
    Curr Cardiol Rep; 2014 Nov; 16(11):542. PubMed ID: 25303896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease.
    Kremens D; Lew M; Claassen D; Goodman BP
    Clin Auton Res; 2017 Jul; 27(Suppl 1):29-31. PubMed ID: 28674867
    [No Abstract]   [Full Text] [Related]  

  • 15. A clinical, physiology and pharmacology evaluation of orthostatic hypotension in the elderly.
    Sahni M; Lowenthal DT; Meuleman J
    Int Urol Nephrol; 2005; 37(3):669-74. PubMed ID: 16307360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthostatic hypotension for the cardiologist.
    Mar PL; Raj SR
    Curr Opin Cardiol; 2018 Jan; 33(1):66-72. PubMed ID: 28984649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility of orthostatic hypotension in symptomatic elderly.
    Ward C; Kenny RA
    Am J Med; 1996 Apr; 100(4):418-22. PubMed ID: 8610728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of autonomic testing for the efficient diagnosis and effective pharmacological management of neurogenic orthostatic hypotension.
    Alam SB; Almardini W; Suleman A
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31434666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fludrocortisone Is Associated With a Higher Risk of All-Cause Hospitalizations Compared With Midodrine in Patients With Orthostatic Hypotension.
    Grijalva CG; Biaggioni I; Griffin MR; Shibao CA
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29025750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orthostatic Hypotension: A Practical Approach to Investigation and Management.
    Arnold AC; Raj SR
    Can J Cardiol; 2017 Dec; 33(12):1725-1728. PubMed ID: 28807522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.